Press Release Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference Aug 10
Press Release Rani Therapeutics Announces Positive Initial Phase 1a Data for RT-114 for the Treatment of Obesity, with Oral Bioavailability Exceeding Matched Subcutaneous Dosing Jul 15